"abciximab" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "w:fragment antigen-binding",
        "3": "-ci-",
        "4": "-ximab",
        "alt1": "(F)_(ab)",
        "t2": "cardiovascular",
        "t3": "chimeric monoclonal antibody"
      },
      "expansion": "fragment antigen-binding + -ci- (“cardiovascular”) + -ximab (“chimeric monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From fragment antigen-binding + -ci- (“cardiovascular”) + -ximab (“chimeric monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "abciximab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English links with redundant alt parameters",
          "parents": [
            "Links with redundant alt parameters",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English links with redundant wikilinks",
          "parents": [
            "Links with redundant wikilinks",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms interfixed with -ci-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -ximab",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Entries with translation boxes",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 4 entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Terms with Finnish translations",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Terms with Italian translations",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Terms with Polish translations",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Terms with Portuguese translations",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Terms with Spanish translations",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_(ab) fragment from a chimeric monoclonal antibody prepared from humans and mice."
      ],
      "id": "en-abciximab-en-noun-u7Iqqr~N",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "anticlotting",
          "anticlotting"
        ],
        [
          "ReoPro",
          "ReoPro"
        ],
        [
          "platelet",
          "platelet"
        ],
        [
          "aggregation",
          "aggregation"
        ],
        [
          "glycoprotein",
          "glycoprotein"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "chimeric",
          "chimeric"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_(ab) fragment from a chimeric monoclonal antibody prepared from humans and mice."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "translations": [
        {
          "code": "fi",
          "lang": "Finnish",
          "sense": "antiplatelet drug",
          "word": "absiksimabi"
        },
        {
          "code": "it",
          "lang": "Italian",
          "sense": "antiplatelet drug",
          "word": "abciximab"
        },
        {
          "code": "pl",
          "lang": "Polish",
          "sense": "antiplatelet drug",
          "word": "abciksimab"
        },
        {
          "code": "pt",
          "lang": "Portuguese",
          "sense": "antiplatelet drug",
          "tags": [
            "masculine"
          ],
          "word": "abciximab"
        },
        {
          "code": "es",
          "lang": "Spanish",
          "sense": "antiplatelet drug",
          "tags": [
            "masculine"
          ],
          "word": "abciximab"
        }
      ],
      "wikipedia": [
        "abciximab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/æbˈsɪk.sɪˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "abciximab"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "w:fragment antigen-binding",
        "3": "-ci-",
        "4": "-ximab",
        "alt1": "(F)_(ab)",
        "t2": "cardiovascular",
        "t3": "chimeric monoclonal antibody"
      },
      "expansion": "fragment antigen-binding + -ci- (“cardiovascular”) + -ximab (“chimeric monoclonal antibody”)",
      "name": "af"
    }
  ],
  "etymology_text": "From fragment antigen-binding + -ci- (“cardiovascular”) + -ximab (“chimeric monoclonal antibody”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "abciximab (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English links with redundant alt parameters",
        "English links with redundant wikilinks",
        "English nouns",
        "English terms interfixed with -ci-",
        "English terms suffixed with -ximab",
        "English uncountable nouns",
        "Entries with translation boxes",
        "Pages with 4 entries",
        "Terms with Finnish translations",
        "Terms with Italian translations",
        "Terms with Polish translations",
        "Terms with Portuguese translations",
        "Terms with Spanish translations",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_(ab) fragment from a chimeric monoclonal antibody prepared from humans and mice."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "anticlotting",
          "anticlotting"
        ],
        [
          "ReoPro",
          "ReoPro"
        ],
        [
          "platelet",
          "platelet"
        ],
        [
          "aggregation",
          "aggregation"
        ],
        [
          "glycoprotein",
          "glycoprotein"
        ],
        [
          "receptor",
          "receptor"
        ],
        [
          "chimeric",
          "chimeric"
        ],
        [
          "monoclonal antibody",
          "monoclonal antibody"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_(ab) fragment from a chimeric monoclonal antibody prepared from humans and mice."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "abciximab"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/æbˈsɪk.sɪˌmæb/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "translations": [
    {
      "code": "fi",
      "lang": "Finnish",
      "sense": "antiplatelet drug",
      "word": "absiksimabi"
    },
    {
      "code": "it",
      "lang": "Italian",
      "sense": "antiplatelet drug",
      "word": "abciximab"
    },
    {
      "code": "pl",
      "lang": "Polish",
      "sense": "antiplatelet drug",
      "word": "abciksimab"
    },
    {
      "code": "pt",
      "lang": "Portuguese",
      "sense": "antiplatelet drug",
      "tags": [
        "masculine"
      ],
      "word": "abciximab"
    },
    {
      "code": "es",
      "lang": "Spanish",
      "sense": "antiplatelet drug",
      "tags": [
        "masculine"
      ],
      "word": "abciximab"
    }
  ],
  "word": "abciximab"
}